Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Cohen, S
Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. [electronic resource] - Arthritis and rheumatism Nov 1999 - 2309-18 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0004-3591
10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K doi
Adolescent
Adrenal Cortex Hormones--adverse effects
Adult
Aged
Aged, 80 and over
Analysis of Variance
Biomarkers
Bone Resorption--chemically induced
Calcium Channel Blockers--adverse effects
Demography
Double-Blind Method
Etidronic Acid--adverse effects
Female
Humans
Male
Middle Aged
Risedronic Acid
Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. [electronic resource] - Arthritis and rheumatism Nov 1999 - 2309-18 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0004-3591
10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K doi
Adolescent
Adrenal Cortex Hormones--adverse effects
Adult
Aged
Aged, 80 and over
Analysis of Variance
Biomarkers
Bone Resorption--chemically induced
Calcium Channel Blockers--adverse effects
Demography
Double-Blind Method
Etidronic Acid--adverse effects
Female
Humans
Male
Middle Aged
Risedronic Acid